The worldwide uterine cancer drugs market size was esteemed at USD 6.3 billion in 2017 and is expected to extend at a CAGR of 5.0% during...

At a CAGR of 10.9%, the cancer/tumour profiling market is expected to grow to USD 13.9 billion from USD 8.3 billion by 2025, totalling...

Adrenocortic carcinoma is rare cancer that affects the outer layer of the adrenal gland which causes some hormones which keep blood...

The overall market for Gynecological Cancer Drugs was worth $9,269 million in 2016 and is expected to be worth $16,107 million by 2023 at...